Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a global population of more than 35 million people living with HIV, there is intense interest in developing a cure for HIV infection. The International AIDS Society convened a group of international experts to develop a scientific strategy for research towards an HIV cure. This Perspective summarizes the group's strategy
Despite considerable global investment, only 60% of people who live with HIV currently receive antir...
Antiretroviral therapy for HIV infection needs lifelong access and strict adherence to regimens that...
The International AIDS Society convened the multi-stakeholder "Towards an HIV Cure" symposium in Kua...
Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a glob...
Antiretroviral therapy is not curative. Given the challenges in providing life-long therapy to a glo...
Given the limitations of antiretroviral therapy and recent advances in our understanding of HIV pers...
Given the limitations of antiretroviral therapy and recent advances in our understanding of HIV pers...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
International audienceThirty years after the identification of HIV, a cure for HIV infection is stil...
With the advent and stunning success of combination antiretroviral therapy (ART) to prolong and impr...
The development of a cure is among the foremost contemporary priorities in the field of HIV research...
Antiretroviral therapy (ART) for HIV infection was oneof the most spectacular scientific advances in...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
Despite considerable global investment, only 60% of people who live with HIV currently receive antir...
Antiretroviral therapy for HIV infection needs lifelong access and strict adherence to regimens that...
The International AIDS Society convened the multi-stakeholder "Towards an HIV Cure" symposium in Kua...
Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a glob...
Antiretroviral therapy is not curative. Given the challenges in providing life-long therapy to a glo...
Given the limitations of antiretroviral therapy and recent advances in our understanding of HIV pers...
Given the limitations of antiretroviral therapy and recent advances in our understanding of HIV pers...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
International audienceThirty years after the identification of HIV, a cure for HIV infection is stil...
With the advent and stunning success of combination antiretroviral therapy (ART) to prolong and impr...
The development of a cure is among the foremost contemporary priorities in the field of HIV research...
Antiretroviral therapy (ART) for HIV infection was oneof the most spectacular scientific advances in...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
Despite considerable global investment, only 60% of people who live with HIV currently receive antir...
Antiretroviral therapy for HIV infection needs lifelong access and strict adherence to regimens that...
The International AIDS Society convened the multi-stakeholder "Towards an HIV Cure" symposium in Kua...